{
    "2018-11-01": [
        [
            {
                "time": "2018-11-01",
                "original_text": "Novo Nordisk (NVO) Reports In-Line Q3 Earnings, Beats Sales",
                "features": {
                    "keywords": [
                        "Q3 Earnings",
                        "In-Line",
                        "Beats Sales"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-01",
                "original_text": "Novo Nordisk (NVO) Q3 2018 Earnings Conference Call Transcript",
                "features": {
                    "keywords": [
                        "Q3 2018",
                        "Earnings",
                        "Conference Call"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-11-01",
                "original_text": "Danish Insulin Maker Novo Nordisk Cuts Jobs, Shifts R&D Spending",
                "features": {
                    "keywords": [
                        "Cuts Jobs",
                        "Shifts R&D Spending"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-11-01",
                "original_text": "Health Care Sector Update for 11/01/2018: TEVA, NVO, SNN, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Sector Update",
                        "TEVA",
                        "NVO",
                        "SNN",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-11-01",
                "original_text": "Upbeat sales lift Novo Nordisk as drugmaker weathers U.S. pricing pressure",
                "features": {
                    "keywords": [
                        "Upbeat sales",
                        "U.S. pricing pressure"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-01",
                "original_text": "Novo Nordisk: 3Q Earnings Snapshot",
                "features": {
                    "keywords": [
                        "3Q Earnings",
                        "Snapshot"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-11-01",
                "original_text": "Novo Nordisk earnings miss expectations amid currency headwinds",
                "features": {
                    "keywords": [
                        "earnings miss",
                        "currency headwinds"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-11-01",
                "original_text": "Novo Nordisk 9-month Profit Rises",
                "features": {
                    "keywords": [
                        "9-month Profit",
                        "Rises"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-01",
                "original_text": "FDA Approves 3rd Humira Biosimilar, CLVS Tanks On Q3 Results, CRY On Watch",
                "features": {
                    "keywords": [
                        "FDA Approves",
                        "Humira Biosimilar",
                        "CLVS Tanks",
                        "Q3 Results"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}